MBT 200
Natural health product licensed in Canada
- Licence holder
- NuSkin Canada Inc.
- NPN or DIN-HM
- 02052660
- Status
- Inactive licence
- Licence date
- 25 October 2007
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium | 25 mg | 50,000 µg |
| Vitamine B12 | 6 mcg | 12 µg |
| Potassium | 20 mg | 40,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Vanillin, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Vitamin, Mineral Supplement with Lipotropic Factors Supports Good Health and Well-being.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of each of children. If you are pregnant or breastfeeding consult your healthcare practitioner prior to using this product. Do not use this product while taking any prescription drug(s) without the advice of a healthcare practitioner. Do not exceed 2 capsules daily
Source
Official Health Canada record, licence 02052660
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.